| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.43 | 4e-10 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-07 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |